Overview

Open-Label Study of Oral Treprostinil in Digital Ulcers

Status:
Terminated
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This open label extension trial will allow ongoing treatment of subjects who participated in the randomized controlled trials, and will provide long term information about the safety of treprostinil diethanolamine SR in subjects with SSc and digital ulcers.
Phase:
Phase 2
Details
Lead Sponsor:
United Therapeutics
Treatments:
Treprostinil